Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.53
-0.01 (-0.18%)
At close: Dec 5, 2025, 4:00 PM EST
5.52
-0.01 (-0.18%)
After-hours: Dec 5, 2025, 6:29 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Antibody-Based Therapeutics
850.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
850.00K